- Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives
- Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests
- LAPIX Therapeutics Announces First Patient Dosed in Phase Ib Study of LPX-TI641 in Atopic Dermatitis
- 1 Day Essential Overview of the Pharmaceutical and Biotech Industries Training Course (ONLINE EVENT: March 12, 2026)
- Cytokinetics Announces FDA Approval of MYQORZOâ„¢ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
- Cryopreservation Bags and Freezing Bags Market Trends and Global Forecasts to 2035: Distribution by Type of Analyte Stored and Key Geographical Regions
- Numab Therapeutics Achieves Milestone in Second Collaboration Project with Boehringer Ingelheim
- Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
- ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
- ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
